What is the price-to-earnings ratio of Biosynex?
The price-earnings ratio of Biosynex is currently 0.33.
Biosynex P/S 2024
Biosynex P/S
0.33
Ticker
ALBIO.PA
ISIN
FR0011005933
WKN
A1H8G1
As of Jul 31, 2024, Biosynex's P/S ratio stood at 0.33, a -68.27% change from the 1.04 P/S ratio recorded in the previous year.
The Biosynex P/S history
Biosynex Aktienanalyse
What does Biosynex do?
The company Biosynex SA was founded in 2005 in Strasbourg, France. The company is a manufacturer and distributor of diagnostic test kits used for the rapid and accurate diagnosis of various infectious diseases and other health conditions. Biosynex SA has established itself as a leading player in the global health market in recent years. The business model of Biosynex SA includes the design, manufacture, and distribution of various medical diagnostic tests that are capable of quickly and efficiently detecting pathogens and other health conditions. The company offers a wide range of medical test kits that can be used for the diagnosis of HIV/AIDS, hepatitis C, syphilis, rapid pregnancy tests, menopause, bleeding during pregnancy, vitamin D deficiency, and many other health conditions. The main focus of Biosynex SA is on developing test kits that are easy to use and provide accurate and reliable results. With its technological know-how and collaboration with leading experts in the field of medical diagnostics, Biosynex SA has taken a leading position in the development and marketing of medical diagnostic test kits. By collaborating with doctors, hospitals, and clinics globally, Biosynex SA has successfully expanded its business. Biosynex SA has various business areas specifically focused on the marketing and distribution of medical diagnostic tests. The most well-known areas include gynecology, infectious diseases, and pediatrics. Biosynex SA also has a strong presence in the global market, including Asia, Europe, Africa, and America. One of the most well-known products of Biosynex SA is the HIV self-test called Autotest VIH®, which is available in many European countries and North America. The test kit is CE marked and approved by leading health authorities such as the WHO and the EU. The product is an important tool in reducing the spread of HIV infections and allowing people to make a confidential diagnosis of HIV/AIDS in a private setting. In the field of gynecology, Biosynex SA offers various products such as the Unistick® pregnancy test, Unistick® ovulation test, and Unistick® menopause test kit. These products enable women to easily and efficiently diagnose pregnancy, ovulation, and menopause. The test kits are easy to use, can be used at home, and provide results within minutes. In summary, Biosynex SA has earned its leading position in the global market due to its focus on innovative technology and high-quality product range. The company has made a significant contribution to improving healthcare worldwide with its expertise and commitment to diagnosing health conditions. Biosynex SA will continue to expand its business in the future to support even more people worldwide and further improve the quality of healthcare. Biosynex ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Biosynex's P/S Ratio
Biosynex's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Biosynex's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Biosynex's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Biosynex’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Biosynex stock
How has the price-earnings ratio of Biosynex changed compared to last year?
The price-to-earnings ratio of Biosynex has increased by -68.27% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Biosynex high compared to other companies?
Yes, the price-to-earnings ratio of Biosynex is high compared to other companies.
How does an increase in the price-earnings ratio of Biosynex affect the company?
An increase in the price-earnings ratio of Biosynex would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Biosynex affect the company?
A decrease in the price-earnings ratio of Biosynex would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Biosynex?
Some factors that influence the price-earnings ratio of Biosynex are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Biosynex pay?
Over the past 12 months, Biosynex paid a dividend of 2 EUR . This corresponds to a dividend yield of about 51.41 %. For the coming 12 months, Biosynex is expected to pay a dividend of 0 EUR.
What is the dividend yield of Biosynex?
The current dividend yield of Biosynex is 51.41 %.
When does Biosynex pay dividends?
Biosynex pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Biosynex?
Biosynex paid dividends every year for the past 2 years.
What is the dividend of Biosynex?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Biosynex located?
Biosynex is assigned to the 'Health' sector.
Wann musste ich die Aktien von Biosynex kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Biosynex from 5/18/2022 amounting to 2 EUR, you needed to have the stock in your portfolio before the ex-date on 5/16/2022.
When did Biosynex pay the last dividend?
The last dividend was paid out on 5/18/2022.
What was the dividend of Biosynex in the year 2023?
In the year 2023, Biosynex distributed 2 EUR as dividends.
In which currency does Biosynex pay out the dividend?
The dividends of Biosynex are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Biosynex
Our stock analysis for Biosynex Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biosynex Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
